Skip to main content

BPH (Benign Prostatic Hyperplasia)

0
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Butterfly Biosciences
Butterfly BiosciencesCA - Marina del Rey
1 program
Butterfly Prostatic Retraction DeviceN/A1 trial
Active Trials
NCT05341661Active Not Recruiting245Est. Dec 2029
Butterfly Medical
Butterfly MedicalIsrael - Yokneam
1 program
Butterfly Prostatic Retraction DeviceN/A
Zenflow
ZenflowCA - South SF
1 program
Zenflow Spring SystemN/A3 trials
Active Trials
NCT07797348Not Yet Recruiting110Est. Sep 2029
NCT07538622Recruiting300Est. Sep 2028
NCT04987138Unknown279Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
ZenflowZenflow Spring System
ZenflowZenflow Spring System
Butterfly BiosciencesButterfly Prostatic Retraction Device
ZenflowZenflow Spring System

Clinical Trials (4)

Total enrollment: 934 patients across 4 trials

NCT07797348ZenflowZenflow Spring System

Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH.

Start: Sep 2026Est. completion: Sep 2029110 patients
Phase 4Not Yet Recruiting
NCT07538622ZenflowZenflow Spring System

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

Start: Jul 2026Est. completion: Sep 2028300 patients
N/ARecruiting
NCT05341661Butterfly BiosciencesButterfly Prostatic Retraction Device

Butterfly Pivotal Study

Start: Apr 2022Est. completion: Dec 2029245 patients
N/AActive Not Recruiting
NCT04987138ZenflowZenflow Spring System

Safety and Effectiveness Study of the Zenflow Spring System

Start: Sep 2021Est. completion: Jun 2026279 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 934 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.